MEDICALLY REVIEWED

Singapore’s HSA approves vericiguat (Verquvo) for use in high-risk heart failure patients with reduced ejection fraction

heart failure vericiguat Verquvo

Log In or Register as a healthcare professional to read the full article.

Share via

Also worth reading

People also read: